GB0427699D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- GB0427699D0 GB0427699D0 GB0427699A GB0427699A GB0427699D0 GB 0427699 D0 GB0427699 D0 GB 0427699D0 GB 0427699 A GB0427699 A GB 0427699A GB 0427699 A GB0427699 A GB 0427699A GB 0427699 D0 GB0427699 D0 GB 0427699D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0427699A GB0427699D0 (en) | 2004-12-17 | 2004-12-17 | Chemical compounds |
NZ555474A NZ555474A (en) | 2004-12-17 | 2005-12-15 | 4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors |
CNA2005800479782A CN101115752A (en) | 2004-12-17 | 2005-12-15 | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
KR1020077016245A KR20070091018A (en) | 2004-12-17 | 2005-12-15 | 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino)benzamides as cdk inhibitors |
AU2005315392A AU2005315392B2 (en) | 2004-12-17 | 2005-12-15 | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors |
BRPI0517426-0A BRPI0517426A (en) | 2004-12-17 | 2005-12-15 | compound, process for preparing same, pharmaceutical composition, use of a compound, and methods for producing an anti-cell proliferation effect, for producing a cdk2 inhibitory effect, and for treating a disease in a warm-blooded animal |
EP05818389A EP1828183A1 (en) | 2004-12-17 | 2005-12-15 | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
PCT/GB2005/004865 WO2006064251A1 (en) | 2004-12-17 | 2005-12-15 | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
CA002589793A CA2589793A1 (en) | 2004-12-17 | 2005-12-15 | 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as cdk inhibitors |
JP2007546187A JP2008524191A (en) | 2004-12-17 | 2005-12-15 | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamide as a CDK inhibitor |
MX2007007272A MX2007007272A (en) | 2004-12-17 | 2005-12-15 | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors. |
US11/793,254 US20090099160A1 (en) | 2004-12-17 | 2005-12-15 | 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
ARP050105322A AR052170A1 (en) | 2004-12-17 | 2005-12-16 | USEFUL PYRIMIDINE DERIVATIVES FOR ITS ANTI-PROLIFERATION CELLULAR ACTIVITY |
TW094144965A TW200635924A (en) | 2004-12-17 | 2005-12-16 | Chemical compounds |
UY29277A UY29277A1 (en) | 2004-12-17 | 2005-12-20 | BENZAMID DERIVATIVES (4 (4- (1-ISOPROPIL-2-METHYL-1H-IMIDAZOL-5-IL) -PIRIMIDIN-2-IL) AMINO) SUBSTITUTES, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURE AND APPLICATIONS |
IL183526A IL183526A0 (en) | 2004-12-17 | 2007-05-29 | 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino)benzamides as cdk inhibitors |
NO20072756A NO20072756L (en) | 2004-12-17 | 2007-05-30 | 4- (4- (imidazol) -4-yl) -pyrimidin-2-ylamino) benzamides as CDK inhibitors |
ZA200705073A ZA200705073B (en) | 2004-12-17 | 2007-06-12 | 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as CDK inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0427699A GB0427699D0 (en) | 2004-12-17 | 2004-12-17 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0427699D0 true GB0427699D0 (en) | 2005-01-19 |
Family
ID=34090251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0427699A Ceased GB0427699D0 (en) | 2004-12-17 | 2004-12-17 | Chemical compounds |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101115752A (en) |
GB (1) | GB0427699D0 (en) |
ZA (1) | ZA200705073B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5982490B2 (en) * | 2011-09-16 | 2016-08-31 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | Disubstituted 5-fluoro-pyrimidine |
EP2909176B1 (en) * | 2012-10-18 | 2016-07-20 | Bayer Pharma Aktiengesellschaft | 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group |
ES2597232T3 (en) * | 2012-10-18 | 2017-01-17 | Bayer Pharma Aktiengesellschaft | 4- (ortho) -fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group |
-
2004
- 2004-12-17 GB GB0427699A patent/GB0427699D0/en not_active Ceased
-
2005
- 2005-12-15 CN CNA2005800479782A patent/CN101115752A/en active Pending
-
2007
- 2007-06-12 ZA ZA200705073A patent/ZA200705073B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200705073B (en) | 2009-05-27 |
CN101115752A (en) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0414438D0 (en) | Chemical compounds | |
EP1713775A4 (en) | Chemical compounds | |
GB0412467D0 (en) | Chemical compounds | |
EP1793826A4 (en) | Chemical compounds | |
EP1708697A4 (en) | Chemical compounds | |
EP1799671A4 (en) | Chemical compounds | |
EP1778231A4 (en) | Chemical compounds | |
GB0406280D0 (en) | Chemical compounds | |
EP1838312A4 (en) | Chemical compounds | |
GB0413389D0 (en) | Chemical compounds | |
GB0412072D0 (en) | Chemical compounds | |
GB0412468D0 (en) | Chemical compounds | |
GB0413953D0 (en) | Chemical compounds | |
GB0413955D0 (en) | Chemical compounds | |
GB0427328D0 (en) | Chemical compounds | |
GB0427699D0 (en) | Chemical compounds | |
GB0411595D0 (en) | Chemical compounds | |
GB0424528D0 (en) | Chemical compounds | |
GB0403781D0 (en) | Chemical compounds | |
GB0413970D0 (en) | Chemical compounds | |
GB0409567D0 (en) | Chemical compounds | |
GB0411592D0 (en) | Chemical compounds | |
GB0409494D0 (en) | Chemical compounds | |
GB0402825D0 (en) | Chemical compounds | |
GB0423041D0 (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |